AN INVESTIGATION OF THE RELATIONSHIP BETWEEN THE
eNOS GENE POLYMORPHISM AND DIAGNOSED MIGRAINE
Güler S1,*, Gürkan H2, Tozkir H2, Turan N3, Çelik Y1
*Corresponding Author: Sibel Güler, M.D., Department of Neurology, Trakya University Faculty of Medicine,
Balkan Yerleşkesi, 22030 Edirne, Turkey. Tel: +90-284-236-49-81. Fax: +90-284-223-42-03. E-mail: drsibleguler@
yahoo.com
page: 49
|
|
REFERENCES
1. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi
M, Archetti S, et al. Endothelial nitric oxide
synthase (Glu298Asp) polymorphism is an
independent risk factor for migraine with aura.
Headache. 2006; 46(10): 1575-1579.
2. Toriello M, Oterino A, Pascual J, Castillo J,
Colás R, Alonso-Arranz A, et al. Lack of association
of endothelial nitricoxide synthase
polymorphisms and migraine. Headache. 2008;
48(7): 1115-1119.
3. Gruber HJ, Bernecker C, Lechner A, Weiss S,
Wallner-Blazek m, Meinitzer A, et al. Increased
nitric oxide stress is associated with migraine.
Cephalalgia. 2010; 30(4): 486-492.
4. Gkaliagkousi E, Douma S, Zamboulis C, Ferro
A. Nitric oxide dysfunction in vascular endothelium
and platelets: Role in essential hypertension.
J Hypertens. 2009; 27(12): 2310-2320.
5. Gonçalves FM, Martins-Oliveira A, Speciali JG,
Luizon MR, Izidoro-Toledo TC, Silva PS, et
al. Endothelial nitric oxide synthase haplotypes
associated with aura in patients with migraine.
DNA Cell Biol. 2011; 30(6): 363-369.
6. Headache Classification Committee, International
Headache Society. The International
Classification of Headache Disorders, 2nd ed.
Cephalalgia. 2004; 24(1): 1-160.
7. Stovner, L, Hagen, K, Jensen, R, Katsarava Z,
Lipton R, Scher A, et al. The global burden of
headache: A documentation of headache prevalence
and disability worldwide. Cephalalgia.
2007; 27(3): 193-210.
8. Gonçalves FM, Luizon MR, Speciali JG, Martins-
Oliveira A, Dach F, Tanus-Santos JE, et al.
Interaction among nitric oxide (NO)-related
genes in migraine susceptibility. Mol Cell Biochem.
2012; 370(1-2): 183-189.
9. Olesen J. The role of nitric oxide (NO) in migraine,
tension-type headache and cluster headache.
Pharmacol Ther. 2008; 120(2): 157-171.
10. Olesen J. Nitric oxide-related drug targets in headache.
Neurotherapeutics. 2010 7(2): 183-190.
11. Sarchielli P, Floridi A, Mancini ML, Rossi C,
Coppola F, Baldi A, et al. NF-κB Activity and
iNOS expression in monocytes from internal
jugular blood of migraine without aura patients
during attacks. Cephalalgia. 2006; 26(9): 1071-
1079.
12. de O S Mansur T, Gonçalves FM, Martins-
Oliveira A, Speciali JG, Dach F, Lacchini R,
et al. Inducible nitric oxide synthase haplotype
associated with migraine and aura. Mol Cell
Biochem. 2012; 364(1-2): 303-308.
13. Lea RA, Curtain RP, Shepherd AG, Brimage PJ,
Griffiths LR. No evidence for involvement of the
human inducible nitric oxide synthase (iNOS)
gene in susceptibility to typical migraine. Am J
Med Genet. 2001; 105(1): 110-113.
14. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y.
Association of the pentanucleotide repeat polymorphism
in NOS2 promoter region with susceptibility
to migraine in a Chinese population.
DNA Cell Biol. 2011; 30(2): 117-122.
15. Noseda R, Kainz V, Jakubowski M, Gooley JJ,
Saper CB, Digre K, et al. A neural mechanism for
exacerbation of headache by light. Nat Neurosci.
2010; 13(2): 239-245.
16. Milhaud D, Bogousslavsky J, van Melle G, Liot
P. Ischemic stroke and active migraine. Neurology.
2001; 57(10): 1805-1811.
17. Olesen J. Nitric oxide-related drug targets in headache.
Neurotherapeutics. 2010; 7(2): 183-190.
18. Napoli R, Guardasole V, Zarra E, Matarazzo M,
D’Anna C, Saccà F, et al. Vascular smooth muscle
cell dysfunction in patients with migraine.
Neurology. 2009; 72(24): 2111-2114.
19. Myers DE. Potential neurogenic and vascular
roles of nitric oxide in migraine headache and
aura. Headache. 1999; 39(2): 118-124.
20. Tanus-Santos JE, Desai M, Flockhart DA. Effects
of ethnicity on the distribution of clinically
relevant endothelial nitric oxide variants. Pharmacogenetics.
2001; 1(8): 719-725.
21. Crawford DC, Nickerson DA. Definition and
clinical importance of haplotypes. Annu Rev
Med. 2005; 56(1): 303-320.
22. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki
S, Desta Z, Flockhart DA, et al. Endothelial
nitric oxide synthase gene haplotypes associated
with circulating concentrations of nitric
oxide products in healthy men. Pharmacogenet
Genomics. 2005; 15(8): 565-570.
23. Wang J, Dudley D, Wang XL. Haplotype-specific
effects on endothelial NO synthase promoter
efficiency: Modifiable by cigarette smoking. Arterioscler
Thromb Vasc Biol. 2002; 22(5): e1-e4.
24. Lauer T, Kleinbongard P, Kelm M. Indexes of
NO bioavailability in human blood. News Physiol
Sci. 2002; 17(6): 251-255.
25. Metzger IF, Sertorio JTC, Tanus-Santos JE. Relationship
between systemic nitric oxide metabolites
and cyclic GMP in healthy male volunteers.
Acta Physiol. 2006; 188(2): 123-127.
26. Metzger IF, Sertório JT, Tanus-Santos JE. Modulation
of nitric oxide formation by endothelial nitric
oxide synthase gene haplotypes. Free Radic
Biol Med. 2007; 43(6): 987-992.
27. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho
WA, Tanus-Santos JE. Endothelial nitric
oxide synthase gene haplotypes affect nitrite
levels in black subjects. Phar-macogenomics J.
2011; 11(6): 393-399.
28. Metzger IF, Luizon MR, Lacchini R, Ishizawa
MH, Tanus-Santos JE. Effects of endothelial
nitric oxide synthase tagSNPs haplotypes on
nitrite levels in Black subjects. Nitric Oxide.
2013; 28(1): 33-38.
29. Sipahi T, Guldiken B, Kabayel L, Palabıyık O,
Oskan H, Kılıç TO, et al. Endothelial nitric oxide
synthase and angiotensin converting enzyme
gene polymorphisms in migraine patients. Arch
Neuropsychiatr. 2013; 50(1): 274-278.
30. Guldiken B, Sipahi T, Guldiken S, Ustundag S,
Budak M, Turgut N, et al. Glu298Asp polymorphism
of the endothelial nitric oxide synthase
gene in Turkish patients with ischemic stroke.
Mol Biol Rep. 2009; 36(6): 1539-1543.
31. Martelletti P, Lulli P, Morellini M, Mariani B,
Pennesi G, Cappellacci S, et al. Chromosome 6pencoded
HLA-DR2 determination discriminates
migraine without aura from migraine with aura.
Hum Immunol. 1999; 60(1): 69-74.
32. Rainero I, Grimaldi LM, Salani G, Valfrè W,
Rivoiro C, Savi L, et al. Association between the
tumor necrosis factor-α –308 G/A gene polymorphism
and migraine. Neurology. 2004; 62(1):
141-143.
33. Rubino E, Fenoglio P, Gallone S, Govone F, Vacca
A, De Martino P, et al. Genetic variants in the
NOTCH4 gene influence the clinical features of
migraine. J Headache Pain. 2013; 14(1): 28-32.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
